Veradigm Inc. · OTC:MDRX
Veradigm — Allscripts Healthcare Solutions — J.P. Morgan Healthcare Conference 2020
23 slides from Veradigm's conference presentation, Jan 14, 2020
Slide 1: Allscripts Healthcare Solutions January 2020 J.P. Morgan Healthcare Conference
Allscripts Healthcare Solutions January 2020 J.P. Morgan Healthcare Conference
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, including the preliminary financial information included in this presentation, are based on the current beliefs and expectati
Slide 3: What Distinguishes Allscripts
What Distinguishes Allscripts Delivering Interoperability Scale – 3rd Largest HIT Company Open EHR Adjacent Growth Platforms Breadth and Depth >$1.25B investment in R&D and ~ 130 patents since 2016 Connecting data sources across the community to improve the health of entire populations
Slide 4: Culture – Giving Back
Culture – Giving Back 18participating offices 30nonprofits supported 59,071meals prepared 35,000pounds of food salvaged Countless lives impacted Annual Global Impact Day Major Partnerships
Slide 5: A Vision for Our Clients for Today and Tomorrow
Systems of Record Systems of Engagement Systems of Analysis Continued Innovations A Vision for Our Clients for Today and Tomorrow
Slide 6: 2019 Was a Year of Progress on Strategic Goals
2019 Was a Year of Progress on Strategic Goals Strong renewal and expansion activity across base including at largest client, Northwell Health and 3rd largest client, PIH HealthNorthwell joint EHR development agreementRetained significant portion of Paragon baseExpanded international presence with S
Slide 7: Solidified Long Term Relationship with Northwell Health
Solidified Long Term Relationship with Northwell Health 2018 2H19 2H19 2H19 Renewed Touchworks Platform for an additional 5 years Innovative Agreement to Create Next Generation EHR Renewed Sunrise Platform Through 2027 Renewed Managed Services Agreement Through 2026 Largest client 23 Hospitals 700+
Slide 8: Unique Growth Platforms
#8 Allscripts’ /All possible Unique Growth Platforms
Slide 9: Leading Ambulatory Share Positions Allscripts to Benefit from Shift to Outpatient
Leading Ambulatory Share Positions Allscripts to Benefit from Shift to Outpatient Source: 2019 American Hospital Association Hospital Statistics Source: Deloitte analysis using data from AHA annual survey and Medicare cost reports (via Truven Health Analytics) Share of outpatient services in hospita
Slide 10: EHRs are a Mature Market
EHRs are a Mature Market What is the market demanding? 01 05 Consumer/Patient Engagement Solutions Predictive Analytics and Optimization Solutions 03 07 Care Coordination between Traditional and Post-Acute Care Basic Clinical and Practice Management Solutions outside the U.S. 02 06 Financial Decisio
Slide 11: Our Investments in New Platforms Allow Us to Meet These New Demand Drivers
Our Investments in New Platforms Allow Us to Meet These New Demand Drivers Machine Learning & CloudNext Generation EHR with Northwell Precision Medicine2bPrecise Consumer/Care Coordination FollowMyHealth, HealthGrid, Careport Data and AnalyticsVeradigm Open Application EcosystemAllscripts Developer
Slide 12: Allscripts is Well Positioned in These Areas
A R E A S B E S T I N C L A S S C O M P E T I T I V E Patient Engagement Financial Decision Support Care Coordination Personalized Medicine Predictive Analytics and Optimization Revenue Cycle Solutions and Services Clinical and Practice Management Solutions outside the U.S. Data Driven Solutions at
Slide 13: Growth Platforms Are Differentiated from Other EHR Companies
Growth Platforms Are Differentiated from Other EHR Companies ~10% of revenuePatient engagement, care coordination and precision medicineSolves key problems for providers as they look to engage patients, improve quality of care, and manage shift to value based careClients are providers inside and out
Slide 14: EHR Adjacent Platforms Provide Multiple Streams of High Margin Growth Opportunities
EHR Adjacent Platforms Provide Multiple Streams of High Margin Growth Opportunities Patient engagementServing the ambulatory and acute care environments, FollowMyHealth is a customizable patient engagement platform that improves the quality of care, outcomes and patient satisfaction Care coordinatio
Slide 15: Veradigm Solutions Address Key Needs for Payer & Life Sciences Companies
Veradigm Solutions Address Key Needs for Payer & Life Sciences Companies Business Health Plans Clinical Workflow Life Sciences Practice Fusion Addressable Market ~$5B ~$8B ~$20B ~$3B Customers Regional & National Payers, PBMs(MA, Medicaid, ACA, Commercial) Providers, Life Sciences,HCIT partners Life
Slide 16: Veradigm Has Significant Momentum Heading into 2020
Veradigm Has Significant Momentum Heading into 2020 Building an ecosystem of connected partners, creating a learning platform of health EvalyticaCloud-based analytics platform Practice Fusioncloud-based EHR Announcing Veradigm Health Partnership with Microsoft Exclusive Partnership withNextGen Acqui
Slide 17: Financial Update
#8 Allscripts’ /All possible mlatelarelel| Update
Slide 18: 2019 Preliminary Results
2019 Preliminary Results $1,090 million to $1,110 million (up 13%-15%), an increase from the prior outlook of $1,050 million to $1,100 million GAAP and Non-GAAP revenue is expected to be between $450 million to $455 million (up 2%-3% YoY on a non-GAAP basis) Reaffirming 2019 non-GAAP EPS outlook pro
Slide 19: Strong Bookings Provide the Foundation for Top Line Growth
Strong Bookings Provide the Foundation for Top Line Growth (1) Reflects midpoint of 2019 guidance of $1,090 to $1,110 million.Dollars in millions. ~14% Growth Momentum broad-based and balanced across inpatient, outpatient and Veradigm Pipeline of new deals remains strong heading into 2020 Indicator
Slide 20: Free Cash Flow is Expected to Improve Significantly in 2020
Free Cash Flow is Expected to Improve Significantly in 2020 Balanced Capital Allocation of Share Repurchase and M&A More Normalized FCF Conversion of ~60% of Non-GAAP Net Income (1) 2019 had significant negative free cash flow items that will not repeat or will decline significantly in 2020~$30M rel
Slide 21: Investment Considerations
Investment Considerations We enable providers, payers and life science companies to optimize value at the point of care Robust, diversified and award-winning solutions portfolio Flexible balance sheet with capacity for investment and capital returns High recurring revenue model Track record of succe
Slide 22: Appendix: Non-GAAP Financial Measures
Appendix: Non-GAAP Financial Measures
Slide 23: Non-GAAP Financial Measures
Non-GAAP Financial Measures This presentation includes references to non-GAAP revenue, non-GAAP earnings per share, Adjusted EBITDA, and free cash flow, which are considered non-GAAP financial measures under Section 101 of Regulation G under the Securities Exchange Act of 1934, as amended. Each of t
Allscripts Healthcare Solutions — J.P. Morgan Healthcare Conference 2020 on 6ix